Virginie Vlaeminck-Guillem

Summary

Affiliation: Hospices Civils de Lyon
Country: France

Publications

  1. ncbi Chronic prostatitis does not influence urinary PCA3 score
    Virginie Vlaeminck-Guillem
    Unité Médicale d Oncologie Moléculaire et Transfert, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Lyon, France
    Prostate 72:549-54. 2012
  2. ncbi [Value of urinary PCA3 test for prostate cancer diagnosis]
    V Vlaeminck-Guillem
    Service de Biologie des Tumeurs Solides, Genomique, protéomique, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, 165, Chemin du Grand Revoyet, 69495 Pierre Benite, France
    Prog Urol 18:259-65. 2008
  3. ncbi Urinary prostate cancer 3 test: toward the age of reason?
    Virginie Vlaeminck-Guillem
    Department of Molecular Oncology and Transfert, Lyon Sud Hospital, Pierre Benite, France
    Urology 75:447-53. 2010
  4. ncbi [Value of PCA3 urinary test for prostate biopsy decision: the Lyon-Sud University Hospital experience]
    Virginie Vlaeminck-Guillem
    Unité médicale d oncologie et transfert, Service de biochimie et biologie moléculaire Sud, Centre Hospitalier Lyon Sud, Pierre
    Ann Biol Clin (Paris) 69:31-9. 2011
  5. ncbi Urinary PCA3 score predicts prostate cancer multifocality
    Virginie Vlaeminck-Guillem
    Department of Medical Unit of Molecular Oncology and Transfer, Medical Faculty of Lyon 1 University, Lyon, France
    J Urol 185:1234-9. 2011
  6. ncbi TM4SF1, a novel primary androgen receptor target gene over-expressed in human prostate cancer and involved in cell migration
    Nathalie Allioli
    Institut de Génomique Fonctionnelle de Lyon, Universite de Lyon, Lyon, France
    Prostate 71:1239-50. 2011

Collaborators

Detail Information

Publications6

  1. ncbi Chronic prostatitis does not influence urinary PCA3 score
    Virginie Vlaeminck-Guillem
    Unité Médicale d Oncologie Moléculaire et Transfert, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Lyon, France
    Prostate 72:549-54. 2012
    ..Whether it also influences potential new biomarkers of prostate cancer (PCa) has to be determined. We conducted a prospective study to evaluate the effect of chronic prostatitis on the PCa urinary marker PCA3...
  2. ncbi [Value of urinary PCA3 test for prostate cancer diagnosis]
    V Vlaeminck-Guillem
    Service de Biologie des Tumeurs Solides, Genomique, protéomique, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, 165, Chemin du Grand Revoyet, 69495 Pierre Benite, France
    Prog Urol 18:259-65. 2008
    ..One of the aims is better selection of those patients who will really benefit from prostate biopsies...
  3. ncbi Urinary prostate cancer 3 test: toward the age of reason?
    Virginie Vlaeminck-Guillem
    Department of Molecular Oncology and Transfert, Lyon Sud Hospital, Pierre Benite, France
    Urology 75:447-53. 2010
    ..Recent studies also have suggested that this test could be used to predict cancer prognosis...
  4. ncbi [Value of PCA3 urinary test for prostate biopsy decision: the Lyon-Sud University Hospital experience]
    Virginie Vlaeminck-Guillem
    Unité médicale d oncologie et transfert, Service de biochimie et biologie moléculaire Sud, Centre Hospitalier Lyon Sud, Pierre
    Ann Biol Clin (Paris) 69:31-9. 2011
    ..This study confirms the clinical value of PCA3 urinary test in helping decision for biopsies in patients with suspected prostate cancer...
  5. ncbi Urinary PCA3 score predicts prostate cancer multifocality
    Virginie Vlaeminck-Guillem
    Department of Medical Unit of Molecular Oncology and Transfer, Medical Faculty of Lyon 1 University, Lyon, France
    J Urol 185:1234-9. 2011
    ..We searched for pathological features that influence the shedding of PCA3 producing prostate cancer cells in urine after digital rectal examination...
  6. ncbi TM4SF1, a novel primary androgen receptor target gene over-expressed in human prostate cancer and involved in cell migration
    Nathalie Allioli
    Institut de Génomique Fonctionnelle de Lyon, Universite de Lyon, Lyon, France
    Prostate 71:1239-50. 2011
    ..The identification of its target genes should provide new candidates that may be implicated in cancer initiation and progression...